Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Current Liabilities: 2016-2025

Historic Total Current Liabilities for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $90.3 million.

  • Organogenesis Holdings' Total Current Liabilities rose 16.87% to $90.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.3 million, marking a year-over-year increase of 16.87%. This contributed to the annual value of $77.5 million for FY2024, which is 3.77% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Total Current Liabilities of $90.3 million as of Q3 2025, which was up 37.18% from $65.8 million recorded in Q2 2025.
  • Organogenesis Holdings' Total Current Liabilities' 5-year high stood at $90.3 million during Q3 2025, with a 5-year trough of $65.1 million in Q1 2025.
  • For the 3-year period, Organogenesis Holdings' Total Current Liabilities averaged around $77.8 million, with its median value being $77.5 million (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 34.99% in 2021, then fell by 23.20% in 2025.
  • Organogenesis Holdings' Total Current Liabilities (Quarterly) stood at $82.7 million in 2021, then dropped by 9.29% to $75.0 million in 2022, then grew by 7.31% to $80.5 million in 2023, then fell by 3.77% to $77.5 million in 2024, then increased by 16.87% to $90.3 million in 2025.
  • Its Total Current Liabilities stands at $90.3 million for Q3 2025, versus $65.8 million for Q2 2025 and $65.1 million for Q1 2025.